Cancer Letters

Cancer Letters

Volume 241, Issue 1, 8 September 2006, Pages 93-101
Cancer Letters

Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer

https://doi.org/10.1016/j.canlet.2005.10.014Get rights and content

Summary

Our data revealed that 59.4% of the bladder cancer specimens showed Aurora-A overexpression, of which 31.8% also had Ha-ras codon-12 mutation; 45.5% were from blackfoot-disease endemic areas in which arsenic exposure is a major environment factor associated with various cancer formation. We further demonstrated that arsenic treatment of the immortalized bladder cell line, E7, increased Aurora-A expression. All together, co-existence of Aurora-A overexpression and Ha-ras mutation suggests a possible additively effect on the tumorigenesis of bladder cancer. In addition, Aurora-A overexpression and up-regulated by arsenic exposure opens a new direction for exploring the occurrence of bladder cancer occurrence in Taiwan.

Introduction

Overexpression of Aurora-A has been detected in several human cancer cell lines and cancers [1], [2], [3]. In proliferation cells, expression levels of Aurora-A mRNA and protein are low at the G1 and S phases and peak at the G2 phase of the cell cycle. The expression levels fall during mitotic exit and into the G1 phase of the next cell cycle [4]. The translated Aurora-A peptide consists of 403 amino acids and has a molecular weight of 46 kDa [1]. Ectopic expression of Aurora-A in mouse NIH3T3 cells and Rat1 fibroblasts causes centrosome amplification and transformation [5], [6], suggesting its crucial role in the development of human cancers.

Ras proteins are important for controlling the activities of cell survival, transformation, and apoptosis through several signaling pathways [7], [8], [9]. Multiple effectors have been found downstream of Ras, including Raf, PI3K, RalGDS, RIN1, MEKK, GAP, NF1, and AF6 [10]. The ras-gene encoded proteins become constitutively active because of the point mutations in their coding sequences, especially at amino acid codons 12, 13, and 61 [11]. Overexpression of Ha-rasV12 oncogene not only transforms NIH3T3 cells but also sensitizes them to various stresses, such as serum deprivation, and lovastatin, tumor necrosis factor-α and 5-FU treatments [12], [13], [14], [15]. In addition, urothelial expression of activated Ha-ras in transgenic mice induced urothelial hyperplasia and superficial papillary bladder cancer [16]. About 30% of human tumors, including bladder cancers, contain mutated Ras oncogene [11]. Some of these cancers also showed overexpression of Aurora-A. Whether there is any relation between the Aurora-A overexpression and Ras gene mutation remains unclear.

The blackfoot-disease (BFD) endemic area is defined in the Southwestern coast of Taiwan [17], [18], [19]. High levels of arsenic and fluorescent substances are detected in the artesian well water in this area [20]. The association between the effects of chronic arsenic exposure in drinking water and the occurrence of a variety of disorders includes higher rate of skin, bladder, renal, and lung cancers in BFD endemic area have been reported [21], [22], [23], [24], [25], [26]. In addition, epidemiological studies have correlated the arsenic exposure and the incidence of bladder cancer [25], [26], which was confirmed by reduced bladder cancer mortality after installation of the tap-water supply system in these arsenic endemic regions [27]. Elevated expression of Aurora-A has been strongly associated with the parameters of clinical aggressiveness, including high histological grade, invasion, increasing rate of metastasis, and decreasing overall survival of patients with bladder cancers [28], but the factors that induce the overexpression of Aurora-A are still unclear.

In the present study, we identified the association between Aurora-A overexpression with Ha-ras codon-12 mutation as well as the association between Aurora-A environmental and environmental factor(s) in bladder cancers. A total of 37 bladder cancer patients were conducted to measure the expression levels of Aurora-A mRNA using quantitative real time PCR, and to detect the Ha-ras codon-12 mutations by single nucleotide polymorphism analysis. The assessment of the environmental factors was obtained from the epidemiological studies [17], [18], [19]. The association between Aurora-A mRNA overexpression level and Ha-ras codon-12 mutation as well as environmental factor (BFD endemic area) were evaluated.

Section snippets

Cell lines and cell culture

Human bladder cancer cell lines TGH8301, TCC-SUP, T24 (ATCC), BFTC905 [29] were maintained in Dulbecco's modified Eagle's medium (DMEM; GIBCO, USA), supplemented with 10% fetal bovine serum (GIBCO) at 37 °C in a 5% CO2 incubator. The immortalized human bladder cell-lines E7 (a gift from Dr Nan-Haw Chow; National Cheng Kong University Hospital) was maintained in F12 medium (GIBCO) supplemented with 10% fetal bovine serum at 37 °C in a 5% CO2 incubator.

Tumor tissues

This study was conducted using 37 patients who

Expression levels of Aurora-A mRNA in five human bladder cancer cell lines

We detected Aurora-A expression at mRNA levels in five human bladder cancer cell lines using Northern blotting. As shown in Fig. 1, the immortalized bladder cells, E7, expressed the lowest level of Aurora-A compared with other bladder-cancer cell lines. All grade III cancer cell lines showed much higher Aurora-A mRNA expression levels compared with immortalized E7 and the grade II TSGH8301 cells. The T24 cell line contains Ha-rasV12 mutation [30] and the BFTC905 cell line was established from

Discussion

Activated Ras proteins contribute significantly to several aspects of the malignant phenotype, including deregulation of tumor-cell growth, programmed cell death as well as invasiveness, and induction of new blood-vessel formation. Tatsuka et al. [31] demonstrated that overexpression of Aurora-A potentiates Ha-ras mediated oncogenic transformation, however, the mechanism remains unclear. Overexpression of Aurora-A, which was observed in human bladder cancers, could promote tumor formation and

Acknowledgements

This work was supported by grant CMFHR9316 from the Chi-Mei Medical Center and grant NSC93-2321-B006-009 from the National Science Council, Taiwan, ROC.

References (40)

  • H. Katayama et al.

    The Aurora kinases: role in cell transformation and tumorigenesis

    Cancer Metastasis Rev.

    (2003)
  • J.R. Bischoff et al.

    A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

    Eur. Mol. Biol. Org. J.

    (1998)
  • H. Zhou et al.

    Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

    Nat. Genet.

    (1998)
  • D.A. Spandidos et al.

    Normal ras genes: their onco-suppressor and pro-apoptotic functions (review)

    Int. J. Oncol.

    (2002)
  • S.L. Campbell et al.

    Increasing complexity of Ras signaling

    Oncogene

    (1998)
  • J.L. Bos

    Ras oncogenes in human cancer: a review

    Cancer Res.

    (1989)
  • H.S. Liu et al.

    Selective activation of oncogenic Ha-ras induced apoptosis in NIH/3T3 cells

    Br. J. Cancer

    (1998)
  • Z.T. Zhang et al.

    Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation

    Oncogene

    (2001)
  • I.C. Ch'i et al.

    A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan

    Am. J. Epidemiol.

    (1968)
  • K.P. Chen et al.

    Epidemiologic studies on blackfoot disease in Taiwan, China. 6. Effect of the piped water supply on occurrence and disease progress of blackfoot disease

    Taiwan Yi Xue Hui Za Zhi

    (1969)
  • Cited by (0)

    View full text